Trial Profile
Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Aug 2021
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary) ; Irinotecan; Sirolimus; Temozolomide
- Indications Neuroectodermal tumours
- Focus Therapeutic Use
- 29 Jul 2021 Status changed from recruiting to completed.
- 09 May 2021 As per Eudra update record, this trial has been completed in Germany.
- 04 May 2020 Planned primary completion date changed from 1 Apr 2020 to 1 Apr 2021.